News

Ideal agent for insomnia not always clear cut


 

EXPERT ANALYSIS AT THE NPA PSYCHOPHARMACOLOGY UPDATE

Dr. Doghramji disclosed that he is a consultant for UCB, Teva Pharmaceuticals, Vanda Pharmaceuticals, and Jazz Pharmaceuticals, and that he holds stock in Merck.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Screening for Restless Legs Syndrome Warranted in IBS
MDedge Neurology
Group Educational Therapy Helps Psychogenic Seizure Patients
MDedge Neurology